Acadia Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases with two core franchises in neuroscience and neuro-rare diseases. We are exploring investments into additional adjacencies in rare diseases (neurology, endocrinology, immunology, metabolic, cardiovascular, nephrology).